Sökning: WFRF:(Vicaut Eric)
> (2020) >
Efficacy and Safety...
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial
-
- Tavenier, Anne H. (författare)
- Isala, Netherlands
-
- Hermanides, Renicus S. (författare)
- Isala, Netherlands
-
- Fabris, Enrico (författare)
- Univ Trieste, Italy
-
visa fler...
-
- Lapostolle, Frederic (författare)
- Hosp Avicenne, France
-
- Silvain, Johanne (författare)
- Sorbonne Univ, France
-
- ten Berg, Jurrien M. (författare)
- St Antonius Hosp, Netherlands
-
- Lassen, Jens F. (författare)
- Odense Univ Hosp, Denmark
-
- Bolognese, Leonardo (författare)
- Azienda Osped, Italy
-
- Cantor, Warren J. (författare)
- Univ Toronto, Canada
-
- Cequier, Angel (författare)
- Univ Barcelona, Spain
-
- Chettibi, Mohamed (författare)
- CHU Frantz Fanon, Algeria
-
- Goodman, Shaun G. (författare)
- Univ Toronto, Canada
-
- Hammett, Christopher J. (författare)
- Royal Brisbane and Womens Hosp, Australia
-
- Huber, Kurt (författare)
- Sigmund Freud Univ, Austria
-
- Janzon, Magnus, 1961- (författare)
- Linköpings universitet,Avdelningen för samhälle och hälsa,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US
-
- Merkely, Bela (författare)
- Semmelweis Univ, Hungary
-
- Storey, Robert F. (författare)
- Univ Sheffield, England
-
- Zeymer, Uwe (författare)
- Klinikum Ludwigshafen, Germany; Inst Herzinfarktforsch, Germany
-
- Ecollan, Patrick (författare)
- Sorbonne Univ, France
-
- Collet, Jean-Phillipe (författare)
- Sorbonne Univ, France
-
- Willems, Frank F. (författare)
- Rijnstate Hosp, Netherlands
-
- Diallo, Abdourahmane (författare)
- Paris VII Univ, France
-
- Vicaut, Eric (författare)
- Paris VII Univ, France
-
- Hamm, ChristianW. (författare)
- Univ Giessen, Germany
-
- Montalescot, Gilles (författare)
- Sorbonne Univ, France
-
- van t Hof, Arnoud W. J. (författare)
- Isala, Netherlands; Zuyderland Med Ctr, Netherlands; Maastricht Univ, Netherlands
-
visa färre...
-
(creator_code:org_t)
- 2019-11-21
- 2020
- Engelska.
-
Ingår i: Thrombosis and Haemostasis. - : GEORG THIEME VERLAG KG. - 0340-6245 .- 2567-689X. ; 120:1, s. 65-74
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background Glycoprotein IIb/IIIa inhibitors (GPIs) in combination with clopidogrel improve clinical outcome in ST-elevation myocardial infarction (STEMI); however, finding a balance that minimizes both thrombotic and bleeding risk remains fundamental. The efficacy and safety of GPI in addition to ticagrelor, a more potent P2Y12-inhibitor, have not been fully investigated. Methods 1,630 STEMI patients who underwent primary percutaneous coronary intervention (PCI) were analyzed in this subanalysis of the ATLANTIC trial. Patients were divided in three groups: no GPI, GPI administration routinely before primary PCI, and GPI administration in bailout situations. The primary efficacy outcome was a composite of death, myocardial infarction, urgent target revascularization, and definite stent thrombosis at 30 days. The safety outcome was non-coronary artery bypass graft (CABG)-related PLATO major bleeding at 30 days. Results Compared with no GPI ( n = 930), routine GPI ( n = 525) or bailout GPI ( n = 175) was not associated with an improved primary efficacy outcome (4.2% no GPI vs. 4.0% routine GPI vs. 6.9% bailout GPI; p = 0.58). After multivariate analysis, the use of GPI in bailout situations was associated with a higher incidence of non-CABG-related bleeding compared with no GPI (odds ratio [OR] 2.96, 95% confidence interval [CI] 1.32-6.64; p = 0.03). However, routine GPI use compared with no GPI was not associated with a significant increase in bleeding (OR 1.78, 95% CI 0.88-3.61; p = 0.92). Conclusion Use of GPIs in addition to ticagrelor in STEMI patients was not associated with an improvement in 30-day ischemic outcome. A significant increase in 30-day non-CABG-related PLATO major bleeding was seen in patients who received GPIs in a bailout situation.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- glycoprotein IIb; IIIa inhibitors; primary percutaneous coronary intervention; STEMI; ticagrelor; bailout; tirofiban; eptifibatide; abciximab
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Tavenier, Anne H ...
-
Hermanides, Reni ...
-
Fabris, Enrico
-
Lapostolle, Fred ...
-
Silvain, Johanne
-
ten Berg, Jurrie ...
-
visa fler...
-
Lassen, Jens F.
-
Bolognese, Leona ...
-
Cantor, Warren J ...
-
Cequier, Angel
-
Chettibi, Mohame ...
-
Goodman, Shaun G ...
-
Hammett, Christo ...
-
Huber, Kurt
-
Janzon, Magnus, ...
-
Merkely, Bela
-
Storey, Robert F ...
-
Zeymer, Uwe
-
Ecollan, Patrick
-
Collet, Jean-Phi ...
-
Willems, Frank F ...
-
Diallo, Abdourah ...
-
Vicaut, Eric
-
Hamm, ChristianW ...
-
Montalescot, Gil ...
-
van t Hof, Arnou ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Thrombosis and H ...
- Av lärosätet
-
Linköpings universitet